Atlas Trials

A Study Evaluating Chemotherapy With Fractionated Cisplatin/Gemcitabine Versus Carboplatin/Gemcitabine in the Treatment of Advanced or Metastatic Urothelial Cancer With Impaired Renal Function.

Clinical trial NCT02240017 · COMPLETED

Trial details

NCT number
NCT02240017
Sponsor
Institut Claudius Regaud
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Advanced Urothelial CancerMetastatic Urothelial Cancer
Start date
2015-01-21
Primary completion
2018-04-10
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.